D-0156-2020 Class II Terminated

Recalled by Glenmark Pharmaceuticals Inc., USA — Mahwah, NJ

FDA drug recall D-0156-2020 was initiated by Glenmark Pharmaceuticals Inc., USA on Oct 22, 2019 and is designated Class II. Reason for recall: Defective Delivery System: complaints for difficulty in pushing the plunger of the applicator. The recall status is terminated (terminated Jun 7, 2021). Affected quantity: 216,840 cartons.

Recall details

Product Type
Drugs
Report Date
Nov 6, 2019
Initiation Date
Oct 22, 2019
Termination Date
Jun 7, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
216,840 cartons

Product description

Estradiol Vaginal Inserts USP, 10 mcg, packaged in a) 8-count Vaginal Inserts (with disposable applicators) per carton (NDC 68462-711-71) and b) 18-count Vaginal Inserts (with disposable applicators) per carton (NDC 68462-711-88), Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Colvale-Bardez, Goa 403 513, India; Manufactured for: Glenmark Pharmaceuticals Inc., Mahwah, NJ 07430.

Reason for recall

Defective Delivery System: complaints for difficulty in pushing the plunger of the applicator.

Distribution pattern

Nationwide in the USA

Code information

Batch numbers: a) 20180514, 20180544, Apr-2020; 20180545, 20180546, 20180588, May-2020; 20190003, Jun-2020; b) 20180515, 20180543, Apr-2020; 20180587, May-2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0156-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0156-2020. Report a data issue: hello@regdatalab.com.